Search company, investor...
Search

Predict your next investment

Venture Capital
sigmasquare.com

See what CB Insights has to offer

Investments

14

Portfolio Exits

3

About SIGMA SQUARE CAPITAL

SIGMA SQUARE CAPITAL is an investment institution focused on high-growth emerging industries. SIGMA SQUARE CAPITAL is an early stage investor in the emerging fields of healthcare, technology, finance, and consumer products.

SIGMA SQUARE CAPITAL Headquarters Location

Beijing,

China

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest SIGMA SQUARE CAPITAL News

ABclonal Biotechnology Closes $93M Series C Financing

Feb 22, 2021

ABclonal Biotechnology, a Woburn, Mass.-based global life science tools and services provider, completed its $92.9m Series C financing. The round was led by Sequoia Capital China and LYFE Capital, with participation from Sigma Square Capital, Kinghall Ventures, and Lucion Capital. Led by Zack Wu, CEO, ABclonal Biotechnology is the parent company of ABclonal Technology, a Massachusetts-based life science […] The post ABclonal Biotechnology Closes $93M Series C Financing appeared first on FinSMEs.

SIGMA SQUARE CAPITAL Investments

14 Investments

SIGMA SQUARE CAPITAL has made 14 investments. Their latest investment was in ABclonal as part of their Series C on December 12, 2020.

CBI Logo

SIGMA SQUARE CAPITAL Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

12/18/2020

Series C

ABclonal

$92.9M

No

14

3/5/2020

Series A - II

WAYTOUS

$14.41M

No

9

7/17/2019

Series A

WAYTOUS

Yes

9

12/17/2018

Series B

Subscribe to see more

Subscribe to see more

10

8/3/2018

Unattributed VC

Subscribe to see more

Subscribe to see more

10

Date

12/18/2020

3/5/2020

7/17/2019

12/17/2018

8/3/2018

Round

Series C

Series A - II

Series A

Series B

Unattributed VC

Company

ABclonal

WAYTOUS

WAYTOUS

Subscribe to see more

Subscribe to see more

Amount

$92.9M

$14.41M

New?

No

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

14

9

9

10

10

SIGMA SQUARE CAPITAL Portfolio Exits

3 Portfolio Exits

SIGMA SQUARE CAPITAL has 3 portfolio exits. Their latest portfolio exit was Novogene on April 13, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

4/13/2021

IPO

$99M

Public

1

5/17/2019

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

7/18/2018

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

4/13/2021

5/17/2019

7/18/2018

Exit

IPO

Acquired

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

Acquirer

Public

Subscribe to see more

Subscribe to see more

Sources

1

10

10

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.